Camilla FleetcroftEX MHRA - Deputy Director of Innovative Devices, Eclevar UK VP clinical and regulatory at ECLEVAR UK
Camilla has a wealth of experience in both clinical and regulatory spaces. Since qualifying as a doctor, she has been working at the MHRA for over 8 years, with a short time spent at SGS. In her role, as Deputy Director for Innovative Devices, she led the development of the future UK regulations for medical devices following Brexit, and is involved with policy makers, regularly interacting with ministers and decision makers.
Prior to that Camilla was the Head of Clinical Investigations and Evaluation at MHRA and before the UK exit from the EU, she represented the MHRA in the EU Clinical Investigations and Evalution working group, leading the drafting for MDCG 2020-05 on Equivalence and working on the practicalities & challenges of the implementation for the MDR requirements for CIs and Clinical Evalution in the UK.